Bruce Vernon

Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

The Royal Society of Edinburgh provides investment advice. The non-profit company is based in Edinburgh, UK and has subsidiaries in the United Kingdom.

BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom.

DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada.

Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables.

British Rail International Ltd. is a company that specializes in the marketing of British Rail products and the marketing of railways products. The company is based in London, UK. British Rail International is ultimately controlled by the Government of France. It was acquired by VFE Partenaires SA on July 01, 1997 for $12.67 million.

Rocket Science Ltd. provides marketing services. The company is headquartered in Bromley, the United Kingdom.

Touch Bionics Ltd. provides prosthetic technologies and supporting services for the people with upper limb deficiencies. Its products develop upper-limb prosthetic technologies and specializes in myoelectronic hand and partial hand solutions, as well as a realistic silicone prostheses that are designed to closely match the skin of the wearer. Touch Bionics was founded in 2003 by David Gow and is headquartered in Livingston, the United Kingdom.

The Scotch Malt Whisky Society Ltd. is a whisky club that offers access to exclusive members areas and whiskies, as well as a 35,000 strong community. The company is based in Edinburgh, UK, and has subsidiaries in Hong Kong and Japan. The British company specializes in single cask whisky, which is hand-picked by their dram cierge membership support team. The company offers specially curated cases, bundles, and tasting packs to let customers explore their unique bottlings. The company also has a wide collection of single malt whiskies, rum, gin, cognac, armagnac, and bourbons. The company was founded in 1983 by Phillip Francis Logan Hills. The Scotch Malt Whisky Society was acquired by Hothouse Brands Ltd from The Glenmorangie Co. Ltd. on December 03, 2015.

Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

PhotoniCare, Inc. develops diagnostic tools. It offers ear imaging tool that uses light-based technology to see through the eardrum. The firm's product ClearView, the first product on the platform through which physicians manages middle ear infections. The company was founded by Ryan M. Nolan, Ryan L. Shelton and Stephen A. Boppart in 2013 and is headquartered in Champaign, IL.

Julz Co LLC (Julz) is a venture capital firm founded in 2016. The firm is headquartered in Chapel Hill, North Carolina.

VWR International LLC engages in the supply and distribution of laboratory equipment. It offers products in the areas of research and development, production, life science, healthcare, safety and industrial, controlled environment, furniture, chromatography, food and beverage analysis, and office supplies. The company was founded in 1852 and is headquartered in Radnor, PA.

SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA.

Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

LUX Assure Ltd. provides technology solutions to monitor difficult-to-detect chemicals used by the oil industry. Its offers CoMic a technology that enables optimization of chemicals used for corrosion protection and OMMICA a testing kit for analyzing the concentration of the thermodynamic hydrate inhibitors methanol and monoethylene glycol in water, crude oil, and condensate. The company was founded by Patrick Hickey on May 30, 2001 and is headquartered in Edinburgh, the United Kingdom.

MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom.

Dentsply Ltd. designs, manufactures, and markets dental care products. Its product line includes artificial teeth, x-ray accessories, pharmaceuticals, brochures, endodontics, impression materials, restoratives, dental sealants, ultrasonic scalers, and crown and bridge materials. The company is headquartered in Cayman Islands, the United Kingdom.

Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom.